Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies
Journal of Medicinal Chemistry · 10.10.2024 · 67 (19) · 16967-16990
DOI: 10.1021/acs.jmedchem.4c01680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 30.09.2024. Verfasst von Maria Inês P S Leitão und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Química Estrutural, Institute of Molecular Sciences and Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Metal-Organic Frameworks, Coordination Complexes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 228 Literaturangaben. Gefördert von: Minist??rio da Educa????o e Ci??ncia.
Abstract (Originalsprache)
Innovative strategies for targeted anticancer therapies have gained significant momentum, with metal complexes emerging as tunable catalysts for more effective and safer treatments. Rational design and engineering of metal complexes enable the development of tailored molecular structures optimized for precision oncology. The strategic incorporation of metal complex catalysts within combinatorial therapies amplifies their anticancer properties. This perspective highlights the advancements in synthetic strategies and rational design since 2019, showing how tailored metal catalysts are optimized by designing structures to release or in situ synthesize active drugs, leveraging the target-specific characteristics to develop more precise cancer therapies. This review explores metal-based catalysts, including those conjugated with biomolecules, nanostructures, and metal-organic frameworks (MOFs), highlighting their catalytic activity in biological environments and their in vitro/in vivo performance. To sum up, the potential of metal complexes as catalysts to reshape the landscape of anticancer therapies and foster novel avenues for therapeutic advancement is emphasized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Química Estrutural, Institute of Molecular Sciences and Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisbon, Portugal.
ORCID-Profile: Maria Inês P S Leitão, Tânia S Morais
Förderung
- Minist??rio da Educa????o e Ci??ncia
Zitieren
APA
Leitão, M. I. P. S., & Morais, T. S. (2024). Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies. Journal of Medicinal Chemistry, 67(19), 16967-16990. https://doi.org/10.1021/acs.jmedchem.4c01680
Vancouver
Leitão MIPS, Morais TS. Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies. Journal of Medicinal Chemistry. 2024;67(19):16967-16990. doi:10.1021/acs.jmedchem.4c01680
BibTeX
@article{Leito2024,
author = {Leitão, Maria Inês P S and Morais, Tânia S},
title = {Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {19},
pages = {16967--16990},
doi = {10.1021/acs.jmedchem.4c01680}
}
EUVIMED